Quinuclidine-based NK-1 antagonists I: 3-benzyloxy-1-azabicyclo[2.2.2]octanes
- 1 June 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (6) , 1361-1366
- https://doi.org/10.1016/s0960-894x(00)80349-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Tachykinin receptor types: Classification and membrane signalling mechanismsNeurochemistry International, 1991
- Pharmacological properties of a potent and selective nonpeptide substance P antagonist.Proceedings of the National Academy of Sciences, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Potent and highly selective neurokinin antagonistsJournal of Medicinal Chemistry, 1990
- Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.Proceedings of the National Academy of Sciences, 1990
- Substance P primes human neutrophil activation: A mechanism for neurological regulation of inflammationBiochemical and Biophysical Research Communications, 1989
- Effect of Neuropeptides on Production of Inflammatory Cytokines by Human MonocytesScience, 1988
- Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of ArthritisScience, 1987
- An unidentified depressor substance in certain tissue extractsThe Journal of Physiology, 1931